Co-founder and CEO of BrainTrip, a startup that unlocks the medical potential of brain waves. We've developed the NeuroAI Platform, a vertical SaaS solution for EEGs and brain implants. The NeuroAI Platform can be used to build "apps" that can decipher brain-wave data. Our first NeuroAI product is the BrainTrip Dementia index (BDI), a CE-certified and marketable test for early dementia detection.But dementia is just the beginning. Using the NeuroAI Platform, we can develop "apps" to detect other brain diseases (ADHD, depression, schizophrenia etc.) using EEG or brain implants. It can also be used for research purposes (e.g. to monitor the efficacy of health-promoting protocols or novel drugs).The NeuroAI Platform is device-agnostic, meaning that it can be paired with any EEG or brain implant. To better understand what we're doing, think of a smartphone. Its functionality depends on the phone itself (hardware), the operating system, and apps. BrainTrip has developed the operating system (NeuroAI Platform) that allows for app development (the BDI) on existing and future hardware (EEGs and brain implants).I'm always on the lookout for new business opportunities that could help BrainTrip become a global powerhouse for brain-health biomarkers.If your Venn diagram of interests also overlaps between neuroscience and entrepreneurship, feel free to connect.